AP NEWS

Global Cardiomyopathy Therapies Market 2019-2023 | Initiatives to Increase Awareness About Disease to Boost Market Growth | Technavio

December 7, 2018

LONDON--(BUSINESS WIRE)--Dec 7, 2018-- analysts forecast the global cardiomyopathy therapies market to grow at a CAGR of close to 2 % during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate during the year-over-year growth.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181207005289/en/

Technavio has released a new market research report on the global cardiomyopathy therapies market for the period 2019-2023. (Graphic: Business Wire)

The increase in number of clinical trials for developing disease-specific therapies for cardiomyopathy treatment is one of the major trends being witnessed in the . There are ongoing clinical trials focused on the development of cardiomyopathy therapies for specific cardiomyopathy treatment. Currently, there are no approved cardiomyopathy therapies that directly target the depressed contractility present in dilated cardiomyopathy. Therefore, companies like MyoKardia is developing a precision medicine called MKY-491, which is designed to address the underlying biomechanical cause of dilated cardiomyopathy and can be used in cardiomyopathy treatment.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global cardiomyopathy therapies market is the initiatives to increase awareness about cardiomyopathy disease:

Global cardiomyopathy therapies market: Initiatives to increase awareness about cardiomyopathy disease

To spread awareness about cardiomyopathy among people, several initiatives have been taken in the last few years. The initiative aims at having at a deeper understanding of the cardiomyopathy disease and build resources thereafter for aiding patients and their caregivers. In addition, the companies also announced collaboration to improve the baseline understanding of unmet needs of the cardiomyopathy disease, including the quality of life, the standard of care, the variability of symptoms and knowledge of disease progression. Thus, rising initiatives to increase awareness about cardiomyopathy disease is expected to drive the market.

According to a senior analyst at Technavio, “Several initiatives are taken by the companies and other organizations for the awareness of the cardiomyopathy therapies. In October 2018, Myokardia undertook an initiative to raise awareness and support cardiomyopathy patients. Also, Abiomed , in February 2018, announced the launch of women’s initiative which aims to provide women with heart recovery education and awareness.”

Global cardiomyopathy therapies market: Segmentation analysis

The global cardiomyopathy therapies market research report provides market segmentation by type (dilated cardiomyopathy, hypertrophic cardiomyopathy, and others) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The Americas held the largest share of the market in 2018, accounting for more than 52% share. It was followed by EMEA and APAC respectively. The dominance of the Americas can be attributed to the initiatives to increase awareness about the disease and rising R&D for cardiomyopathy treatment.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005289/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH CARDIOLOGY RESEARCH SCIENCE

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 12/07/2018 10:16 AM/DISC: 12/07/2018 10:16 AM

http://www.businesswire.com/news/home/20181207005289/en

AP RADIO
Update hourly